LOCAL DECISIONS ON SMC ADVICE
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |
Medicines are listed alphabetically - please select from above. For a listing by month refer to the ADTC Supplements which are published to the Tayside Area Formulary homepage.
Full
information on any of the medicines listed can be found using the link to the
Scottish Medicines Consortium (SMC) website to search by generic, brand or SMC
No. See 'Links to Additional Information' below for website address.
Medicines that have been
assessed using the
SMC ultra-orphan pathway
are listed
HERE. These medicines are
subject to initial SMC assessment of the clinical and cost-effectiveness.
Prescribing of these medicines is subject to a further period of data
collection before further review by SMC.
NHS Board New Medicines Decisions - National Standard Template
Work has been undertaken nationally by the ADTC Collaborative led by Health Improvement Scotland to develop standardised wording for use by Health Boards in recording local implementation of Scottish Medicines Consortium decisions. CLICK HERE for full details with an explanation of the six categories that came into effect from May 2016.
Links
to Additional Information:
For full details of
medicines and forthcoming SMC Advice
see SMC
Website: |
For a Summary of a Product’s Characteristics (SPCs) see Electronic Medicines
Compendium Website: |
Monthly Drug Safety Updates:
www.gov.uk/government/publications/drug-safety-update-monthly-newsletter
|